Company Ticker News June 29, 2021Could Biogen's Big Win With Aduhelm Become a Big Liability? 0 0 Share
Company Ticker News June 28, 2021Biogen's Costly Alzheimer's Treatment May Face Restricted Medicare Access: WSJ 0 0 Share
Company Ticker News June 25, 2021How Will the Drop in Biogen's Share Price Hit Buffett's Portfolio? 0 0 Share
Press Release June 25, 2021Samsung Bioepis and Biogen Receive Positive CHMP Opinion for Ranibizumab Biosimilar, BYOOVIZ™ 0 0 Share
Company Ticker News June 23, 2021Biogen now says it plans to complete 'confirmatory' study for Alzheimer's drug earlier than required 0 0 Share
Company Ticker News June 22, 2021The Wall Street Journal: FDA approved Biogen Alzheimer's drug despite some objections by staff 0 0 Share
